Left to right : Jongmoon Kim, ToolGen CEO and Alan Trounson, Cartherics CEO shook hands and signed the papers whilst Cartherics Chairman Bob Moses looked on.
By Leigh Dayton, Cartherics […]
5 September 2019
Using the tools of biotechnology and immunology to help transforming cancer from a fatal to a manageable — or even curable – disease holds profound benefits to individual patients and the […]
As of July, the number of scientists sharing the work load in Cartherics’ laboratory hit an even dozen. That’s thanks to Research Fellow and haematologist Madeline Cao who joined the team from CSIRO where she worked on haematopoietic stem cells with Susie Nilsson’s group.
At Cartherics her focus is […]
Cartherics’ Chairman Bob Moses has over 40 years of executive experience in life science companies. You name it, he’s been there: Eli Lilly, ICI Australia, CSL Limited, Freehills, Amrad, Meditech, Daratech, Australian Stem Cell Centre, TGR Biosciences, and two Cooperative Research Centres.
Based on his depth of […]
Ms Rasa Islam is Cartherics’ first full-time PhD student. She’s joining the team under a prestigious Cooperative Research Centre (CRC) Project Grant entitled “Allogeneic Stem Cell Cancer immunotherapies”.
As part of the CRC-P Program, Cartherics offers high calibre students PhD research programs of study that include international level research training, […]
Research Assistant Callum Docherty explains why immunology is his passion and advancing cancer therapy is his goal.
I’ve always had an insatiable curiosity and a passion for big-picture ideas. Growing up both my mother and grandmother had cancer. After such an early confrontation with the absence of health — something most of us take for granted […]
Cartherics Communications Adviser Leigh Dayton reveals the lengths Cartherics co-founder and immunologist Richard Boyd will go to for a good conversation.
It was a dark and stormy night. OK, that’s a slight exaggeration, but it was the day Richard Boyd was flying from Melbourne to Sydney […]
WHAT PISSES ME OFF
When it comes to taking ideas to market, Corporate Advisor Ian Nisbet says America’s entrepreneurial ethos leaves risk-averse Australia in the innovation dust.
I’VE WORKED my whole career in the biotechnology/pharmaceutical industry. Sometimes in business development, sometimes in drug development, sometimes in project management, sometimes in […]
 |
 |
IMMUNOLOGIST Jacques Miller did not win this year’s Nobel Prize in Physiology or Medicine. He didn’t win it last year or the year before that. In fact, the French-born Australian has […]
WELCOME to The Pipeline, the place where Cartherics team members share occasional news and views.
To get things rolling, Communications Adviser Leigh Dayton talked with cancer immunologist Ashleigh Unsworth, Cartherics’ latest recruit. Ashleigh joins the company from Peter MacCallum Cancer Centre where she conducted breast cancer research while […]